Apis Capital Advisors’s scPharmaceuticals SCPH Stock Holding History

Apis Capital Advisors’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-440,000	Closed	-$2.49M	–	52
2025 Q3	$2.49M	Sell	440,000 -312,000	-41%	-$1.6M	0.55%	31
2025 Q2	$2.87M	Buy	752,000 +247,053	+49%	+$767K	1.02%	25
2025 Q1	$1.33M	Buy	504,947 +110,947	+28%	+$361K	0.64%	33
2024 Q4	$1.39M	Buy	394,000 +234,000	+146%	+$896K	0.93%	23
2024 Q3	$730K	Buy	+160,000	New	+$774K	0.51%	28

Apis Capital Advisors's SCPH Position: Q4 2025 in Review

Apis Capital Advisors sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 440,000 shares — an estimated $2.49M sold.

Apis Capital Advisors first reported a position in SCPH in Q3 2024 and held it in 5 quarters. The position peaked at $2.87M in Q2 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Apis Capital Advisors reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Apis Capital Advisors sold 440,000 scPharmaceuticals shares in Q4 2025, an estimated $2.49M.
Apis Capital Advisors first reported a position in scPharmaceuticals in Q3 2024 and held it in 5 quarters.
Apis Capital Advisors's scPharmaceuticals position peaked at $2.87M in Q2 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Apis Capital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.